Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

  • Meltem Polat, Soner Sertan Kara
  • Infection and Drug Resistance, November 2017, Dove Medical Press
  • DOI: 10.2147/idr.s148703

The authors haven't yet claimed this publication.

open access logoRead Publication

http://dx.doi.org/10.2147/idr.s148703